Detalhe da pesquisa
1.
A case of autoimmune pulmonary alveolar proteinosis during the course of treatment of rapidly progressive interstitial pneumonia associated with anti-MDA5 antibody-positive dermatomyositis.
BMC Pulm Med
; 24(1): 170, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589870
2.
Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib.
Respir Investig
; 62(3): 388-394, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460356
3.
Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation.
Respir Med Case Rep
; 43: 101818, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36950026
4.
Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.
Clin Rheumatol
; 42(2): 479-488, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194347
5.
Vanishing tumefactive ANCA-associated hypertrophic pachymeningitis: A case report.
Clin Neurol Neurosurg
; 212: 107070, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894573
6.
Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.
Cells
; 11(1)2022 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35011705
7.
Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.
Thorac Cancer
; 13(22): 3225-3228, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193787
8.
A pregnant woman with severe dyspnoea.
Breathe (Sheff)
; 18(2): 220012, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36337132
9.
A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia.
Radiol Case Rep
; 16(11): 3504-3508, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34422150